EU Pharmaceutical Law Forum
1050 Brussels, Belgium
Event summary
Cooley is pleased to participate in Informa Connect’s EU Pharmaceutical Law Forum, a premier gathering of legal and regulatory leaders shaping pharmaceutical law in Europe. The forum convenes stakeholders from across the European Commission, European Medicines Agency, competition authorities and top pharmaceutical organisations to explore critical legal developments impacting the life sciences industry.
Our life sciences and healthcare regulatory team will be on the ground, engaging with peers and contributing to discussions on regulatory strategy, enforcement trends and emerging risks at the intersection of healthcare data, privacy and compliance. We look forward to connecting with colleagues and industry partners in Brussels.
Featured agenda item
21 May // 10:40 am CEST
Navigating FDA Uncertainty: Impacts on Regulatory Strategy
Cooley partner Sonia Nath will speak on this quick‑fire regulatory briefing examining how evolving US Food and Drug Administration (FDA) policies and enforcement priorities are shaping regulatory decision‑making. The session will address the implications of regulatory uncertainty for global pharmaceutical strategy and compliance planning.
Related Contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.